OneAscent Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

OneAscent Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,202	Closed	-$227K	–	157
2022 Q3	$227K	Sell	2,202 -2,014	-48%	-$191K	0.12%	128
2022 Q2	$392K	Sell	4,216 -873	-17%	-$82.3K	0.2%	78
2022 Q1	$597K	Buy	5,089 +813	+19%	+$94.2K	0.3%	52
2021 Q4	$575K	Buy	4,276 +13	+0.3%	+$1.93K	1.43%	19
2021 Q3	$679K	Buy	+4,263	New	+$583K	0.77%	16
2021 Q1	$1.01M	Buy	7,868 +1,978	+34%	+$301K	0.43%	48
2020 Q4	$982K	Buy	+5,890	New	+$974K	0.44%	45

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

OneAscent Wealth Management's ASND Position: Q4 2022 in Review

OneAscent Wealth Management sold out of Ascendis Pharma A/S (ASND) in Q4 2022, closing a stake of 2,202 shares — an estimated $227K sold.

OneAscent Wealth Management first reported a position in ASND in Q4 2020 and held it in 7 quarters. The position peaked at $1.01M in Q1 2021. 187 funds tracked by Wall St. Rank hold ASND as of Q4 2022.

OneAscent Wealth Management reported no remaining Ascendis Pharma A/S position as of Q4 2022 after selling out during the quarter.
OneAscent Wealth Management sold 2,202 Ascendis Pharma A/S shares in Q4 2022, an estimated $227K.
OneAscent Wealth Management first reported a position in Ascendis Pharma A/S in Q4 2020 and held it in 7 quarters.
OneAscent Wealth Management's Ascendis Pharma A/S position peaked at $1.01M in Q1 2021.
187 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2022.

Based on OneAscent Wealth Management's 13F filing for Q4 2022, filed 12 Jan 2023.